BLOMBERG, Germany, Dec. 18, 2023 /PRNewswire/ — During a press conference at the SPS automation trade fair in Nuremberg, Germany, Ulrich Leidecker, Chief Operating Officer of Phoenix Contact, spoke about the company’s economic development, which, after two years of above-average growth, has been characterized by a significant decline in incoming orders since the second quarter of 2023.… Continue reading Phoenix Contact plans an extensive investment program for medium to long-term growth
Category: Newswire
Global Personal Care UV Filters Business Analysis Report 2023: Market to Reach $1 Billion by 2030 – Beauty Brands Speed Up Sun Care Innovations Targeting UV Filter Technology
DUBLIN, Dec. 18, 2023 /PRNewswire/ — The “Personal Care UV Filters – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Personal Care UV Filters Market to Reach $1 Billion by 2030 The global market for Personal Care UV Filters estimated at US$784.8 Million in the year 2022, is projected to reach a… Continue reading Global Personal Care UV Filters Business Analysis Report 2023: Market to Reach $1 Billion by 2030 – Beauty Brands Speed Up Sun Care Innovations Targeting UV Filter Technology
TruStage™ and SIGNiX Collaborate to Expand Digital Signature Options for all Clients
Financial institutions gain efficiencies in document content and digital signature functionality. MADISON, Wis., Dec. 18, 2023 /PRNewswire/ — TruStage™ announced today a collaboration between its compliance solutions offering, which has more than four decades of experience with financial documentation and supports more than 5,400 financial institutions, and SIGNiX, a leading provider of digital signature solutions. This… Continue reading TruStage™ and SIGNiX Collaborate to Expand Digital Signature Options for all Clients
TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D
EDINBURGH, Scotland, Dec. 18, 2023 /PRNewswire/ — TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, announced today that the creation of a new Commercial Development Division, which will be headed by Dr. Lauren Bor, PhD. The new division will… Continue reading TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D
1 to 4 million people are predicted travel to the Total Solar Eclipse, creating the biggest travel event of the year on April 8, 2024
Great American Eclipse reports data-driven eclipse tourism projection numbers SANTA FE, N.M., Dec. 18, 2023 /PRNewswire/ — On April 8, 2024, a Total Solar Eclipse will sweep across the United States from Texas to Maine sending millions of Americans into darkness. 31 million Americans currently live inside the path of totality. Millions more will travel… Continue reading 1 to 4 million people are predicted travel to the Total Solar Eclipse, creating the biggest travel event of the year on April 8, 2024
GRIP Molecular Technologies and Molecular Testing Labs Announce Collaborative Development of Groundbreaking At-Home Disease Testing Platform
ST. PAUL, Minn. and VANCOUVER, Wash., Dec. 18, 2023 /PRNewswire/ — Intending to reshape the landscape of at-home medical diagnostic testing, GRIP Molecular Technologies (GRIP) and Molecular Testing Labs (MTL) announced today that their collaboration has culminated in a successful clinical feasibility study of a state-of-the-art electronic biosensor technology that intends to bring lab-quality, multi-disease… Continue reading GRIP Molecular Technologies and Molecular Testing Labs Announce Collaborative Development of Groundbreaking At-Home Disease Testing Platform
DIABETES RESEARCH INSTITUTE PIONEERS FIRST-EVER ANALYSIS OF LIVE HUMAN PANCREAS REGENERATION WITH TYPE 1 DIABETES
MIAMI, Dec. 18, 2023 /PRNewswire/ — In a groundbreaking development, the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine recently announced significant progress in their mission to find a cure for diabetes, now. Led by principal investigator Juan Dominguez-Bendala, Ph.D., the novel study used live slices of the human pancreas.… Continue reading DIABETES RESEARCH INSTITUTE PIONEERS FIRST-EVER ANALYSIS OF LIVE HUMAN PANCREAS REGENERATION WITH TYPE 1 DIABETES
Venus Aerospace Applauds Hypersonic Investments in FY2024 NDAA
HOUSTON, Dec. 18, 2023 /PRNewswire/ — Venus Aerospace, an industry leader in hypersonic aviation, applauded the inclusion of robust investments in hypersonic capabilities in the Fiscal Year 2024 National Defense Authorization Act (NDAA) passed by Congress. Continue Reading Key provisions direct further research and development funding for reusable hypersonic multi-mission aircraft along with additional resources… Continue reading Venus Aerospace Applauds Hypersonic Investments in FY2024 NDAA
Global Sewage Treatment Facilities Industry Report 2023: Market to Reach $221.6 Billion by 2030 – Increase in Industrial Activities Shifts Focus onto Effective Facilities
DUBLIN, Dec. 18, 2023 /PRNewswire/ — The “Sewage Treatment Facilities – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Sewage Treatment Facilities Market to Reach $221.6 Billion by 2030 The global market for Sewage Treatment Facilities estimated at US$130.4 Billion in the year 2022, is projected to reach a revised size… Continue reading Global Sewage Treatment Facilities Industry Report 2023: Market to Reach $221.6 Billion by 2030 – Increase in Industrial Activities Shifts Focus onto Effective Facilities
FMC Investors Have Opportunity to Lead FMC Corporation Securities Fraud Lawsuit
BENSALEM, Pa., Dec. 18, 2023 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against FMC Corporation (“FMC” or the “Company”) (NYSE: FMC). Class Period: February 9, 2022 – October 30, 2023 Lead Plaintiff Deadline: January 8, 2024 Investors suffering losses… Continue reading FMC Investors Have Opportunity to Lead FMC Corporation Securities Fraud Lawsuit